https://www.alzforum.org/news/research- ... mers-genes
There is so much potential to totally unlock the AD genome.
With full genome scans approaching ~$100 perhaps full genome sequencing could become common in AD clinical trials
and these sequences (with patient approval) could be analyzed in GWAS. Fully unlocking the full AD GWAS would tell us so much. It really should be done sooner than later.
We know that at a scale of ~1 -2 million everything would be revealed. This isn't an eternal money pit searching a bottomless void.
Basically, $100 million. If we make it a project for the people, might reduce down to scrounging some CPU from morally conscious tech titans and possibly some takeout.